Other data suggested that the RUNX1/PRDM16 fusion gene could contribute to immortalization of the leukemic stem cell and play an important role during clonal evolution from chronic myeloid leukemia (CML) to AML and imatinib resistance [223,224]. This evidence concerns the gene PRDM16 and chronic myelogenous leukemia, BCR-ABL1 positive.